Logiscreen

FocalTherics

$4.75
Market Cap 70.79M
ROE 0.0%
Gross Margin 0.0%
Debt/Equity 0.0
Current Ratio 0.0
Revenue QoQ 0.0%
EPS QoQ 0.0%
F-Score 0

About

A recognized leader in the robotic energy-based therapies, EDAP TMS develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery, EDAP TMS introduced the Focal One ® in Europe and in the U.S. as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer.

Exchange
NASDAQ
Sector
Healthcare
Industry
Medical Devices

Sector context

Healthcare

Undervalued

Trading at a discount to sector peers

P/E
-3.36
vs median 35.63
P/B
27.23
vs median 2.25
ROE
-1.55
vs median 0.09

Lower quality - review fundamentals carefully

Small-cap company with higher volatility

Similar companies

Primary metric
Overlay metric
Loading chart data...
Fetching latest financial metrics